Warner Biddle
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Warner Biddle currently works at Kyverna Therapeutics, Inc., as Chief Executive Officer & Director from 2024.
Mr. Biddle also formerly worked at Genentech, Inc., as Vice President-Sales & Marketing and Kite Pharma, Inc., as Senior Vice President & Global Head-Commercial.
Mr. Biddle received his undergraduate degree from the University of Saskatchewan.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Algemeen Directeur | 16-09-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Verkoop & Marketing | - |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
University of Saskatchewan
University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau